Supplements

Citrus Bergamot for Cholesterol: What the Research Actually Shows

·HealthyMag Editorial Team
Fresh bergamot citrus fruit, one sliced open, on a rustic table

This article contains affiliate links. We only recommend products we have independently researched. Reviewed by the HealthyMag Editorial Team. Last updated: November 2026.

Quick Answer: Citrus bergamot extract has lowered LDL (“bad”) cholesterol and triglycerides in small human trials, but how much depends on whose trial you read. The large drops quoted online, LDL down 23% at 500 mg and about 39% at 1,000 mg a day, come from one 2011 study of a branded extract called BPF. Two small trials of the same extract by an independent group, at 500 and 1,000 mg in patients on antipsychotics, found no significant change in cholesterol, and a 2026 trial of a different extract (150 mg of flavonoids a day, 108 adults) found LDL down 7.0%. A 2026 meta-analysis of 9 randomised trials rated the certainty of every result “low to very low”. It is not a replacement for a statin, and people on cholesterol, blood-thinning or diabetes medication should talk to a doctor first.

If you have read about a citrus fruit that lowers cholesterol “like a natural statin,” you have almost certainly encountered citrus bergamot. The claims sound almost too tidy: an extract from a small, sour Italian orange that shaves double-digit percentages off your LDL, nudges your HDL upward, and even helps trim triglycerides — all without a prescription. Some of that is genuinely supported by human research. Some of it is marketing built on a thin and imperfect evidence base. This article walks through exactly what bergamot is, what the trials actually measured, where the science is weak, and how to think about it honestly if you are considering it for your heart health.

What citrus bergamot actually is

Bergamot (Citrus bergamia) is a citrus fruit grown almost exclusively along the Calabrian coast of southern Italy. You have probably tasted its aromatic oil already — it is what gives Earl Grey tea its distinctive perfume. The fruit itself is too bitter to eat, but its juice and peel are unusually rich in a group of plant compounds called flavonoids.

The supplement world is interested in one specific extract: the bergamot polyphenolic fraction, usually abbreviated BPF. It is a concentrate of the flavonoids in bergamot juice, mainly neoeriocitrin, neohesperidin and naringin. In the 2011 study that launched the cholesterol claims, the researchers reported that BPF inhibited HMG-CoA reductase, the enzyme statins block, which is where the “natural statin” framing comes from. An enzyme effect in a lab is not the same thing as a statin’s clinical record, as the sections below show.

When you compare bergamot supplements, the meaningful number is not the milligrams of fruit extract but the polyphenol or flavonoid content, because that is what the trials dosed. As the section on BPF below explains, the trials did not all use the same extract, and the word “BPF” on a label does not tell you which one you are buying.

The cholesterol and lipid evidence: what the trials found

Bergamot’s reputation rests on a handful of human trials, most published since 2011. Here is what they showed, with the numbers we could check.

The foundational study (Mollace et al., 2011). The most-cited study gave BPF for 30 days to 237 patients with high blood lipids, some also with high blood sugar, and reported lower total and LDL cholesterol, lower triglycerides, higher HDL and lower blood glucose. Its abstract gives no percentages. A 2019 review of the trials reports them: LDL down 23% at 500 mg a day and 38.6% at 1,000 mg; total cholesterol down 20% and 30.9%; HDL up 25.9% and 39%. These are the numbers behind most of the bold claims you see online, and they come from a single study.

Added to a statin (Gliozzi et al., 2013). In a prospective, open-label study of 77 patients, groups of 15 or 16 people took placebo, rosuvastatin 10 mg, rosuvastatin 20 mg, BPF 1,000 mg, or BPF 1,000 mg plus rosuvastatin 10 mg, for 30 days. The authors concluded that adding BPF “significantly enhanced rosuvastatin-induced effect on serum lipemic profile compared to rosuvastatin alone.” As tabulated in the 2019 review, LDL fell from an average of 191 mg/dL to 115 on rosuvastatin 10 mg, 87 on rosuvastatin 20 mg, 113 on BPF alone, and 90 on BPF plus rosuvastatin 10 mg. That hints bergamot might let some people reach a target on less statin, but with about 15 people per group and no blinding it is a hypothesis, not a treatment plan.

A different extract over 6 months (Toth et al., 2016). An uncontrolled study of 80 adults with moderately high cholesterol used Bergavit R, a bergamot juice extract, at 150 mg of flavonoids a day. After 6 months LDL fell from 4.6 to 3.7 mmol/L (about 178 to 143 mg/dL), triglycerides from 1.8 to 1.5 mmol/L, and HDL rose from 1.3 to 1.4 mmol/L. The share of small, dense LDL particles fell. There was no placebo group, so some of the change could have happened anyway.

A better-absorbed formulation (Mollace et al., 2019). A double-blind, placebo-controlled trial of 60 people with type 2 diabetes and mixed hyperlipidemia compared standard BPF with a lecithin-bound “phytosome” version. Both lowered fasting glucose, LDL and triglycerides and raised HDL against placebo. The phytosome raised naringin absorption at least 2.5-fold, but the authors found “no differences” in the clinical response between the two forms. Five of its authors work for Indena, the company that makes phytosome formulations.

Study (year)Design / sizeExtract and doseReported lipid changes
Mollace, 2011237 patients; 30 daysBPF 500 or 1,000 mg/dayLDL −23% / −38.6%; HDL +25.9% / +39% (as reported in a 2019 review)
Gliozzi, 2013Open-label, placebo-controlled; 77 people; 30 daysBPF 1,000 mg/day, alone or with rosuvastatin 10 mgLDL 191 → 113 (BPF alone), 90 (BPF + rosuvastatin 10 mg) mg/dL
Toth, 2016Uncontrolled; 80 people; 6 monthsBergavit R, 150 mg flavonoids/dayLDL 4.6 → 3.7 mmol/L; triglycerides 1.8 → 1.5; HDL 1.3 → 1.4
Mollace, 2019Double-blind, placebo-controlled; 60 people with type 2 diabetesBPF or BPF phytosomeLDL and triglycerides down, HDL up vs placebo; no difference between forms

The reviews that pool these trials are cautious. A 2020 systematic review of 12 studies found LDL reductions ranging from 7.6% to 40.8% and noted that “scientific quality of studies was quite limited.” A 2026 meta-analysis of 9 randomised trials with 615 participants found LDL lower by an average of 39.53 mg/dL, but rated six of the nine trials poor, judged the certainty of evidence “low to very low” for every outcome, and said the results “should not be interpreted as establishing the clinical efficacy of bergamot.” The three BPF trials above, from 2011, 2013 and 2019, all come from the same university group in Catanzaro, in Calabria, where bergamot is grown.

How bergamot may work

The proposed mechanisms are plausible and partly overlap with how statins work. Bergamot’s brutieridin and melitidin appear to inhibit HMG-CoA reductase, the same rate-limiting enzyme in cholesterol production that statins block — though far more weakly. Bergamot polyphenols may also reduce cholesterol absorption in the gut, increase the body’s clearance of LDL, and activate AMPK, an enzyme involved in fat and glucose metabolism. On top of the lipid effects, the flavonoids are antioxidants, which may explain the reductions in oxidized LDL and vascular stress markers seen in several trials.

The recurring observation that bergamot shifts LDL toward larger, “fluffier” particles is worth noting, because small dense LDL is more strongly linked to plaque formation than LDL number alone. If that finding holds up in larger trials, it would be a meaningful point in bergamot’s favor. For now it is promising rather than proven. If you are exploring botanicals for metabolic and cardiovascular markers more broadly, our science-based guide to anti-inflammatory supplements covers how to judge this kind of mechanistic evidence without overreading it.

Bergamot versus statins — and as an add-on

This is where honesty matters most, because the “natural statin” label oversells the picture. Statins are among the most rigorously studied drugs in medicine, with large randomized trials and decades of outcome data showing they reduce heart attacks, strokes, and death in higher-risk people. Bergamot has nothing remotely comparable. There is not a single large trial showing bergamot prevents cardiovascular events — every study above measured cholesterol numbers, not heart attacks or survival. Lowering a lab value is encouraging, but it is not the same as proving you live longer or avoid a cardiac event.

So bergamot is not a like-for-like statin substitute, and no one with established heart disease or a high-risk profile should stop a prescribed statin to take it. Where it looks more interesting is as a potential complement: the Gliozzi data suggest it might help people who are statin-intolerant at higher doses, or who want to reach a target on a lower statin dose. That is a conversation to have with a physician who can monitor your labs — not a decision to make alone based on a supplement label. For people focused on the lifestyle and supplement side of metabolic health, it sits alongside other researched options like berberine for blood sugar, which carries its own mix of genuine evidence and overhype.

Bergamot BPF: what the word means on a label, and the dose in each trial

“BPF” is shorthand for bergamot polyphenolic fraction, and in the trials it names one specific extract used by the Catanzaro group (written BPF® in the 2019 paper). Other trials used other extracts and dosed them by flavonoid content instead. Here is every trial on this page by the extract it used, including the two that were not flattering.

TrialExtractDaily doseWhoResult
Mollace 2011BPF500 or 1,000 mg237 patients with high lipidsLipids and glucose improved
Gliozzi 2013BPF1,000 mg77 patients, open-labelLDL 191 → 113 mg/dL alone
Bruno 2017BPF1,000 mg, 30 days15 outpatients on antipsychoticsBody weight down; “no significant differences” in cholesterol or other metabolic parameters
Bruno 2017BPF500 mg, 60 days28 outpatients on antipsychotics“Did not change clinical and metabolic parameters”
Toth 2016Bergavit R150 mg flavonoids80 adults, no placeboLDL 4.6 → 3.7 mmol/L
Yu 2026Flavonoid-standardised extract375 mg (150 mg flavonoids), 4 months108 adultsTotal cholesterol −7.3%, LDL −7.0%

Two things follow. First, the two BPF trials run outside the Catanzaro group, both at the University of Messina in people taking antipsychotics, found no significant change in cholesterol, at 1,000 mg as well as at 500 mg. Those were small pilot studies in a specific group, but they are the only independent tests of the same extract. Second, the trials that used about 150 mg of flavonoids a day from other extracts found smaller changes, in the single-digit percentages in the 2026 trial, than the 2011 BPF study. In the 2026 trial, one author is an employee of the extract’s supplier.

Bergamot dosage and how to choose a product

The trials used two kinds of dose: 500 to 1,000 mg a day of BPF, with the clearer results at 1,000 mg, or about 150 mg a day of flavonoids from other standardised extracts. Most measured results after 30 days; the longest ran 4 to 6 months. No trial compared morning with evening, or taking it with or without food, so there is no tested best time to take it. If you try it, have your lipid panel checked before you start and again after two to three months, so you are judging your own numbers rather than someone else’s average.

When comparing products, the things that actually matter are:

  • Polyphenol or flavonoid content in milligrams. “1,000 mg bergamot” or a 20:1 extraction ratio tells you little; a stated polyphenol or flavonoid amount lets you match a trial dose. Many bergamot labels, especially liquids, give only an extraction ratio.
  • Third-party testing. Look for verification from an independent lab, or a published certificate of analysis, for potency and contaminants.
  • A simple formula. Some products add artichoke, olive leaf, or vitamin C; that is fine, but it makes it harder to attribute any effect to bergamot itself.

Is bergamot safe?

In the published trials, bergamot extract was generally well tolerated over 30 days to 6 months. Most trials reported few or no side effects, and several did not report them at all; the problems that were named were heartburn and dizziness, in a handful of people. The honest limitation is duration: there is very little data beyond 6 months, and no large long-term safety studies.

A practical note: the dietary supplement is not the same as bergamot essential oil. Bergamot essential oil applied to skin can cause photosensitivity (a sunburn-like reaction with UV exposure), and essential oils should never be swallowed as a cholesterol remedy. The cholesterol research is on the standardized oral polyphenol extract only. For what the oral trials actually recorded, and why most side-effect lists describe the essential oil, see our page on citrus bergamot side effects.

Drug interactions and who should avoid it

This is the most important safety section, and it is where bergamot’s citrus heritage becomes relevant. Bergamot is botanically related to grapefruit and Seville orange, and it contains furanocoumarins — notably bergamottin — that can inhibit the CYP3A4 enzyme in your gut. CYP3A4 is responsible for metabolizing many common medications, which is the same mechanism behind the well-known “don’t eat grapefruit with these drugs” warnings. In theory, a furanocoumarin-rich bergamot extract could raise blood levels of CYP3A4-metabolized drugs. The degree of risk depends on the specific product and how it is processed, and we found no human study measuring a bergamot extract’s effect on CYP3A4 — which is exactly why caution is warranted until one exists.

Talk to a doctor or pharmacist before using bergamot if you:

  • Take a statin — both because of the potential CYP3A4 interaction (some statins are metabolized by it) and because bergamot may add to the cholesterol-lowering effect in ways that need monitoring.
  • Take blood thinners such as warfarin, or antiplatelet drugs — no study has tested bergamot with them, and these drugs leave little room for error.
  • Take any CYP3A4-metabolized medication — this includes certain blood pressure drugs, immunosuppressants, some sedatives, and others. The grapefruit-interaction list is a reasonable proxy.
  • Are pregnant or breastfeeding — there is no adequate safety data, so it should be avoided.
  • Have diabetes and take glucose-lowering medication — fasting glucose fell in the 2019 trial in people with type 2 diabetes, and the 2026 meta-analysis found glucose lower by about 12 mg/dL, so doses may need monitoring.

The simplest rule: if you would be told to avoid grapefruit with your medication, treat bergamot supplements with the same caution until a clinician clears you.

🛒 Where to buy: Look for a standardized citrus bergamot (BPF) supplement, third-party tested. One that matches that spec: BergaMet citrus bergamot 1200 mg, 80% polyphenols (Amazon). (As an Amazon Associate we earn from qualifying purchases.)

Cholesterol is only one of the uses people buy bergamot for. For what human trials found on blood sugar, weight, fatty liver, blood pressure, thinking skills and the essential oil, see our overview: citrus bergamot benefits, tested one by one.

Frequently Asked Questions

Does citrus bergamot really lower cholesterol?

In small human trials it lowered LDL cholesterol and triglycerides and raised HDL. The size of the effect varies a lot: a 2011 study of 1,000 mg of BPF reported LDL down about 39%, while a 2026 trial of a different extract found 7.0%. A 2026 meta-analysis of 9 randomised trials found an average LDL reduction of about 40 mg/dL but rated the certainty “low to very low”.

What is BPF in bergamot?

BPF stands for bergamot polyphenolic fraction, a concentrate of the flavonoids in bergamot juice. In the research it refers to a specific extract studied by one university group in Calabria at 500 to 1,000 mg a day. Other trials used other extracts dosed at about 150 mg of flavonoids, so a “BPF” label alone does not tell you which extract or dose you are getting.

How much bergamot should I take?

The trials used either 500 to 1,000 mg a day of BPF, with clearer results at 1,000 mg, or about 150 mg a day of flavonoids from other standardised extracts. Two small independent trials of BPF, at 500 and 1,000 mg, found no significant change in cholesterol. Check the label for the polyphenol or flavonoid amount, and check with a clinician if you take any medication.

When should I take citrus bergamot?

No trial has compared times of day or taking it with or without food, so there is no evidence-based best time. Taking it at the same time each day makes it easier to stay consistent for the 30 days to 6 months the trials ran.

Can you take bergamot with a statin?

Possibly, but only under medical supervision. One small study found that adding bergamot to a low-dose statin lowered LDL about as much as doubling the statin dose — which is intriguing — but bergamot can also interact with the CYP3A4 enzyme that metabolizes some statins. Do not combine them on your own; ask your doctor, who can monitor your labs and adjust doses.

How long does bergamot take to lower cholesterol?

Most studies measured results after 30 days, with continued or maintained improvement over 6 months in the longer trial. A reasonable approach is to recheck your lipid panel after about 8 to 12 weeks of consistent use to see whether it is actually working for you.

Does bergamot have side effects?

Trials describe it as well tolerated over 30 days to 6 months. The side effects that were named were heartburn and dizziness in a few people, and several trials did not report side effects at all. Long-term safety beyond 6 months has not been studied.

Is citrus bergamot the same as bergamot essential oil?

No. The cholesterol research is on a standardized oral polyphenol extract (BPF), not the aromatic essential oil used in tea and perfume. Bergamot essential oil should never be swallowed as a cholesterol remedy and can cause skin photosensitivity when applied topically.

Who should not take bergamot?

Avoid it, or seek medical clearance first, if you are pregnant or breastfeeding, take blood thinners, take statins or other CYP3A4-metabolized drugs, or take diabetes medication. As a grapefruit relative, bergamot can affect how some medications are processed.

Is bergamot better than a statin?

No. Statins have large, long-term trials proving they reduce heart attacks, strokes, and deaths. Bergamot has only shown improvements in cholesterol numbers in small studies — no trial has demonstrated it prevents cardiovascular events. It may be a reasonable complementary option for some people, but it is not a proven replacement for prescribed therapy.

The Bottom Line

Citrus bergamot is one of the more credible cholesterol supplements on the market — which is genuine praise in a category full of empty claims. Human trials have found lower LDL and triglycerides and higher HDL, but the largest effects come from one 2011 study, two small independent trials of the same extract found no change in cholesterol, and the 2026 meta-analysis rated the certainty low to very low. The add-on-to-statin data are especially interesting. But the evidence is also modest: small studies, short durations, frequent open-label designs, three of the four headline trials from one research group, and zero proof that it prevents actual heart attacks or strokes. Treat it as a promising adjunct, not a substitute for proven medical care. Choose a standardized, third-party-tested product, recheck your labs after a couple of months, and — because bergamot is a grapefruit relative with real drug-interaction potential — loop in your doctor or pharmacist before you start, particularly if you take a statin, a blood thinner, or any medication you have been told to keep away from grapefruit.

🛒 Where to buy: citrus bergamot

Herbal Lab’s Italian citrus bergamot is an alcohol-free liquid extract in a vegetable glycerin base, 20:1, 1,500 mg per dropper, 60 servings, third-party lab tested and made in the USA. It supports cardiovascular wellness, and drops suit people who would rather not swallow capsules — you add them to half a glass of water. One thing we would want you to know before you choose: the label gives the extraction ratio rather than a polyphenol percentage, so if matching a standardised BPF figure matters to you, ask them for the certificate of analysis or use a capsule that states the percentage on the bottle.

See Herbal Lab bergamot (15% off)

Affiliate link — we may earn a commission at no extra cost to you, and it does not change what we have written above. Code HERBAL15 is applied at checkout. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Sources

  1. Mollace V, Sacco I, Janda E, et al. Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies. Fitoterapia. 2011;82(3):309-16. PubMed 21056640. 237 patients, BPF for 30 days; abstract gives no percentages. Checked 13 November 2026.
  2. Nauman MC, Johnson JJ. Clinical application of bergamot (Citrus bergamia) for reducing high cholesterol and cardiovascular disease markers. Integr Food Nutr Metab. 2019. PMC6497409 (PubMed 31057945). Reports Mollace 2011: LDL −23% (500 mg) and −38.6% (1,000 mg), total cholesterol −20% and −30.9%, HDL +25.9% and +39%; tabulates Gliozzi 2013 LDL 191, 115, 87, 113 and 90 mg/dL. Checked 13 November 2026.
  3. Gliozzi M, Walker R, Muscoli S, et al. Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia. Int J Cardiol. 2013;170(2):140-5. PubMed 24239156. Prospective, open-label; 77 patients; groups of 15-16; BPF 1,000 mg/day for 30 days. Checked 13 November 2026.
  4. Toth PP, Patti AM, Nikolic D, et al. Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study. Front Pharmacol. 2016;6:299. PubMed 26779019. 80 adults; Bergavit R, 150 mg flavonoids/day; LDL 4.6 to 3.7 mmol/L, triglycerides 1.8 to 1.5, HDL 1.3 to 1.4. Checked 13 November 2026.
  5. Mollace V, Scicchitano M, Paone S, et al. Hypoglycemic and Hypolipemic Effects of a New Lecithin Formulation of Bergamot Polyphenolic Fraction: A Double Blind, Randomized, Placebo-Controlled Study. Endocr Metab Immune Disord Drug Targets. 2019;19(2):136-143. PubMed 30501605. 60 patients with type 2 diabetes and mixed hyperlipemia; naringin absorption at least 2.5-fold; “No differences” in response between forms; five authors from Indena S.p.A. Checked 13 November 2026.
  6. Bruno A, et al. Metabolic outcomes of bergamot polyphenolic fraction administration in patients treated with second-generation antipsychotics. J Nutr Biochem. 2017. PubMed 27846426. 15 outpatients, BPF 1,000 mg/day for 30 days; body weight P = .004; “No significant differences in other and metabolic parameters”. University of Messina. Checked 13 November 2026.
  7. Bruno A, et al. Low-Dose of Bergamot-Derived Polyphenolic Fraction (BPF) Did Not Improve Metabolic Parameters in Second Generation Antipsychotics-Treated Patients. Front Pharmacol. 2017. PubMed 28443024. 28 outpatients, 500 mg/day for 60 days; “did not change clinical and metabolic parameters”. Checked 12 October 2026.
  8. Yu X, et al. Lipid Metabolism Modulation by a Flavonoid-Standardized Citrus Bergamia Extract in an Asian Population. J Exp Pharmacol. 2026. PubMed 42592560. 108 adults, 4 months, 375 mg/day providing 150 mg flavonoids; total cholesterol −7.3%, LDL −7.0%; one author employed by the extract supplier. Checked 12 October 2026.
  9. Lamiquiz-Moneo I, Giné-González J, Alisente S, et al. Effect of bergamot on lipid profile in humans: A systematic review. Crit Rev Food Sci Nutr. 2020;60(18):3133-3143. PubMed 31670973. 12 studies; LDL −7.6% to −40.8%; “scientific quality of studies was quite limited”. Checked 13 November 2026.
  10. Chambari M, Mardani H, Roshandel M, et al. Bergamot (Citrus bergamia) Supplementation and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis. Food Sci Nutr. 2026;14(9):e72357. PubMed 42746152. 9 RCTs, 615 participants; LDL WMD −39.53 mg/dL; glucose −12.12 mg/dL; six trials poor; certainty “low to very low”. Checked 13 November 2026.
Related Reading: Earl Grey Tea Benefits: What the Tea and the Bergamot Do
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making any health decisions. Content reviewed by the HealthyMag Editorial Team.

If you are here because a statin caused muscle symptoms rather than because of cholesterol numbers alone, the CoQ10 question has its own evidence: two systematic reviews disagree, and neither found it helped anyone stay on their statin.

Related